334 results on '"Hsu, Cheng‐Lung"'
Search Results
2. Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways
3. Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy
4. Molecular Diagnosis of Nasopharyngeal Carcinoma: Past and Future
5. The Synergy of 177Lu-FAPI-046 with Tyrosine Kinase Inhibitor in a Sarcoma Patient-Derived Xenograft Mouse Model
6. Prognostic Significance of Granuloma and Amyloid Deposition in Nasopharyngeal Carcinoma
7. Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study.
8. Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy.
9. Pretreatment 18F-FDG PET/CT texture parameters provide complementary information to Epstein-Barr virus DNA titers in patients with metastatic nasopharyngeal carcinoma
10. Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma
11. Incorporation of Astragalus polysaccharides injection during concurrent chemoradiotherapy in advanced pharyngeal or laryngeal squamous cell carcinoma: preliminary experience of a phase II double-blind, randomized trial
12. The synergy of 177Lu-FAPI-46 with tyrosine kinase inhibitor in a sarcoma patient-derived xenograft mouse model
13. Prognostic factors of metastatic testicular non-seminomatous germ cell tumors after chemotherapy
14. Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma
15. Increase of Androgen-Induced Cell Death and Androgen Receptor Transactivation by BRCA1 in Prostate Cancer Cells
16. Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma
17. Abstract 6404: Clinical scenario of immune checkpoint inhibitor treatment in metastatic nasopharyngeal carcinoma
18. Feasibility of percutaneous radiological gastrostomy using the trocar technique and 14-fr pigtail catheter without gastropexy
19. What should we expect from robotic surgery for second primary oropharyngeal cancer?
20. Maintenance tegafur-plus-uracil after adjuvant concurrent chemoradiotherapy may improve outcome for resected oral cavity squamous cell carcinoma with extranodal extension
21. Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types.
22. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
23. Inactivation of the tight junction gene CLDN11 by aberrant hypermethylation modulates tubulins polymerization and promotes cell migration in nasopharyngeal carcinoma
24. Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma
25. The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma
26. Interaction of Cell Cycle Regulatory Proteins with the Androgen Receptor
27. Life quality improvement in hoarse patients with early glottic cancer after transoral laser microsurgery
28. α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer
29. # 1788 Androgen receptor expression decreases recurrence of hepatocellular carcinoma after liver resection
30. A Patient-Derived Xenograft Model of Dedifferentiated Endometrial Carcinoma: A Proof-Of-Concept Study for the Identification of New Molecularly Informed Treatment Approaches
31. Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas
32. Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial
33. Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer
34. Prognostic implications of post-therapy 18F-FDG PET in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
35. Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis
36. Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study
37. Gonadotropin‐releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin‐releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study
38. Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment
39. Prognostic value of pretreatment 18F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma
40. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: A possible alternative for primary screening of nasopharyngeal carcinoma
41. A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma
42. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up
43. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging
44. Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity
45. Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer.
46. Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model
47. Plasma epstein-barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma
48. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis
49. MULTIPLEXED IMMUNOBEAD-BASED PROFILING OF CYTOKINE MARKERS FOR DETECTION OF NASOPHARYNGEAL CARCINOMA AND PROGNOSIS OF PATIENT SURVIVAL
50. Small-Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Rare Case Lacking Association With Epstein-Barr Virus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.